Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMC 2891375)

Published in Am J Transplant on May 10, 2010

Authors

K D S Watt1, R A Pedersen, W K Kremers, J K Heimbach, M R Charlton

Author Affiliations

1: Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA. watt.kymberly@mayo.edu

Articles citing this

Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol (2014) 3.88

Post-transplant malignancy in liver transplantation: a single center experience. Medicine (Baltimore) (2014) 1.44

Liver transplantation in alcoholic liver disease current status and controversies. World J Gastroenterol (2013) 1.30

Infections in liver transplant recipients. World J Hepatol (2011) 1.14

Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation (2012) 1.03

New perspectives for preventing hepatitis C virus liver graft infection. Lancet Infect Dis (2016) 0.91

Management of recurrent hepatitis C following liver transplantation. Gastroenterol Hepatol (N Y) (2010) 0.89

Early respiratory complications after liver transplantation. World J Gastroenterol (2013) 0.88

Long-term medical management of the liver transplant recipient: what the primary care physician needs to know. Mayo Clin Proc (2012) 0.86

Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases. HPB (Oxford) (2012) 0.85

Irreversible liver failure: treatment by transplantation: part 3 of a series on liver cirrhosis. Dtsch Arztebl Int (2013) 0.83

Keys to long-term care of the liver transplant recipient. Nat Rev Gastroenterol Hepatol (2015) 0.83

Chloride-liberal fluids are associated with acute kidney injury after liver transplantation. Crit Care (2014) 0.82

Metabolic and cardiovascular complications in the liver transplant recipient. Ann Gastroenterol (2015) 0.82

NAFLD and liver transplantation: Current burden and expected challenges. J Hepatol (2016) 0.81

Long-term survival after liver transplantation for alcoholic liver disease. World J Gastroenterol (2013) 0.81

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities. World J Gastroenterol (2014) 0.80

Cardiac troponin elevation predicts mortality in patients undergoing orthotopic liver transplantation. J Transplant (2013) 0.80

Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study. J Immunol Res (2014) 0.80

Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies. Dig Dis Sci (2011) 0.80

Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol (2012) 0.79

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. Int J Mol Sci (2016) 0.78

Challenges in transplantation for alcoholic liver disease. World J Gastroenterol (2014) 0.78

Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation. Liver Transpl (2012) 0.78

Management of immunosuppressant agents following liver transplantation: Less is more. World J Hepatol (2016) 0.78

Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study. Medicine (Baltimore) (2015) 0.77

Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation. Adv Chronic Kidney Dis (2015) 0.77

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation (2015) 0.77

Liver transplantation: Current status and challenges. World J Gastroenterol (2016) 0.76

Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl (2014) 0.76

Posttransplant metabolic syndrome. Int J Hepatol (2012) 0.76

Coronary Interventions before Liver Transplantation Might Not Avert Postoperative Cardiovascular Events. Tex Heart Inst J (2015) 0.76

Weight gain, overweight and obesity in solid organ transplantation--a study protocol for a systematic literature review. Syst Rev (2015) 0.76

Comparing outcomes of donation after cardiac death versus donation after brain death in liver transplant recipients with hepatitis C: a systematic review and meta-analysis. Can J Gastroenterol Hepatol (2013) 0.76

Metabolic complications in liver transplant recipients. World J Gastroenterol (2016) 0.76

Donor liver steatosis: A risk factor for early new-onset diabetes after liver transplantation. J Diabetes Investig (2016) 0.75

Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients. Oncotarget (2016) 0.75

Current Issues in Liver Transplantation. Gastroenterol Hepatol (N Y) (2016) 0.75

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation (2017) 0.75

Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World J Gastroenterol (2016) 0.75

Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant Survival. Med Sci Monit (2016) 0.75

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. J Clin Transl Hepatol (2016) 0.75

End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease. Clin Transplant (2014) 0.75

Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report. Int J Surg Case Rep (2016) 0.75

Solid, non-skin, post-liver transplant tumors: Key role of lifestyle and immunosuppression management. World J Gastroenterol (2016) 0.75

Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. World J Gastroenterol (2016) 0.75

β-cell function prior to liver transplantation contributes to post-operative diabetes. Biomed Rep (2016) 0.75

Non-alcoholic fatty liver disease: An expanded review. World J Hepatol (2017) 0.75

Sinonasal evaluation and treatment before liver transplantation: a retrospective review of 982 patients. Eur Arch Otorhinolaryngol (2014) 0.75

Abdominal drainage after liver transplantation from deceased donors. Langenbecks Arch Surg (2015) 0.75

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. World J Hepatol (2017) 0.75

Risk factors and outcomes associated with alcohol relapse after liver transplantation. World J Hepatol (2017) 0.75

Elizabethkingia Meningoseptica in a Case of Biliary Tract Infection Following Liver Transplantation. Am J Case Rep (2017) 0.75

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo. J Korean Med Sci (2017) 0.75

Articles cited by this

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med (1999) 22.81

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73

Analysis of causes of death in liver transplant recipients who survived more than 3 years. Liver Transpl (2001) 1.40

Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology (2009) 1.35

The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant (2008) 1.22

Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. Transplantation (2006) 1.22

Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18

The NIDDK liver transplantation database. Liver Transpl Surg (1997) 1.15

Late mortality after orthotopic liver transplantation. Am J Surg (2001) 1.12

Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl (2002) 1.11

Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Liver Transpl (2004) 1.08

Long-term results after liver transplantation. Transpl Int (2007) 1.00

Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc (2005) 0.98

The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation (2002) 0.98

Improving outcomes of liver retransplantation: an analysis of trends and the impact of Hepatitis C infection. Am J Transplant (2008) 0.97

Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. Transplantation (2008) 0.96

The burden of new-onset diabetes mellitus after transplantation. Clin Transplant (2006) 0.87

Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience. Transplant Proc (2006) 0.87

The hepatitis C virus-associated dysmetabolic syndrome. Hepatology (2008) 0.84

Articles by these authors

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature (1995) 4.56

Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development (1998) 4.08

Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev (1995) 3.80

MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76

Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain. Genes Dev (1995) 3.27

Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development (1991) 3.11

Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77

Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches. Dev Biol (1997) 2.71

Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev Biol (1999) 2.64

Dlx5 regulates regional development of the branchial arches and sensory capsules. Development (1999) 2.19

Integrin alpha8beta1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell (1997) 2.09

Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86

Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83

A murine AP-endonuclease gene-targeted deficiency with post-implantation embryonic progression and ionizing radiation sensitivity. Mutat Res (1998) 1.74

Liver and intestine transplantation in the United States 1998-2007. Am J Transplant (2009) 1.73

The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. Development (1993) 1.67

Blastomeres arising from the first cleavage division have distinguishable fates in normal mouse development. Development (2001) 1.66

Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year. Am J Transplant (2015) 1.61

Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev (1989) 1.57

Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut (2008) 1.56

Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant (2008) 1.56

Mouse numb is an essential gene involved in cortical neurogenesis. Proc Natl Acad Sci U S A (2000) 1.49

OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48

Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther (2010) 1.40

Cell fate and cell lineage in the endoderm of the presomite mouse embryo, studied with an intracellular tracer. Dev Biol (1986) 1.31

Cell fate, morphogenetic movement and population kinetics of embryonic endoderm at the time of germ layer formation in the mouse. Development (1987) 1.30

Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant (2008) 1.27

Two alkaline phosphatase genes are expressed during early development in the mouse embryo. Development (1990) 1.26

Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology (1999) 1.26

Embryonic expression of human keratin 18 and K18-beta-galactosidase fusion genes in transgenic mice. Dev Biol (1993) 1.26

Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant (2007) 1.25

Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23

The impact of obesity on long-term outcomes in liver transplant recipients-results of the NIDDK liver transplant database. Am J Transplant (2008) 1.22

Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state. Nat Commun (2011) 1.20

Origin of the inner cell mass in mouse embryos: cell lineage analysis by microinjection. Dev Biol (1986) 1.17

Polarity of the mouse embryo is anticipated before implantation. Development (1999) 1.17

Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology (1999) 1.14

Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12

Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev (1992) 1.12

Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant (2012) 1.12

Allocation of cells to inner cell mass and trophectoderm lineages in preimplantation mouse embryos. Dev Biol (1982) 1.11

Degradation of extracellular matrix by mouse trophoblast outgrowths: a model for implantation. J Cell Biol (1983) 1.08

Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant (2008) 1.07

Parental imprinting of the Mas protooncogene in mouse. Nat Genet (1994) 1.07

Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ (2011) 1.06

Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant (2012) 1.04

Clonal analysis of cell fate during gastrulation and early neurulation in the mouse. Ciba Found Symp (1992) 1.04

Hatching, attachment, and outgrowth of mouse blastocysts in vitro: fixed nitrogen requirements. J Exp Zool (1973) 1.04

Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl (2000) 1.02

Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology (2000) 1.02

Prosthetic joint infection in solid organ transplant recipients: a retrospective case-control study. Transpl Infect Dis (2012) 1.01

Mechanisms of genomic imprinting in mammals. Curr Top Dev Biol (1994) 1.01

Mutation of the Emx-1 homeobox gene disrupts the corpus callosum. Dev Biol (1996) 1.01

Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl (2001) 1.01

TNF receptor I mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide. J Surg Res (2001) 1.00

Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. Am J Transplant (2009) 1.00

Cultured mouse embryos metabolize benzo[a]pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proc Natl Acad Sci U S A (1980) 0.99

Ultrastructural observations of lethal yellow (Ay/Ay) mouse embryos. J Embryol Exp Morphol (1976) 0.99

Ultraviolet-light-induced unscheduled DNA synthesis by resting and growing mouse oocytes. Mutat Res (1978) 0.98

Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology (1999) 0.98

Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) (2008) 0.97

Morphology of mouse egg cylinder development in vitro: a light and electron microscopic study. J Exp Zool (1977) 0.96

Characterization of erythrocyte quality during the refrigerated storage of whole blood containing di-(2-ethylhexyl) phthalate. Blood (1984) 0.95

Multilocus genetic analysis of single interphase cells by spectral imaging. Hum Genet (2000) 0.94

Abnormal development of embryonic and extraembryonic cell lineages in parthenogenetic mouse embryos. Dev Dyn (1994) 0.94

Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocysts. Genesis (2001) 0.94

Elevated DNA excision repair capacity in the extraembryonic mesoderm of the midgestation mouse embryo. Exp Cell Res (1996) 0.92

Intermittent downbeat nystagmus and oscillopsia reversed by suboccipital craniectomy. Neurology (1980) 0.92

The mini-micro-epididymal sperm aspiration for sperm retrieval: a study of urological outcomes. Hum Reprod (1998) 0.92

Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation (2000) 0.91

Fate of the inner cell mass in mouse embryos as studied by microinjection of lineage tracers. Dev Biol (1988) 0.91

Impact of MELD on waitlist outcome of retransplant candidates. Am J Transplant (2010) 0.91

Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol (2000) 0.90

Repair of the ultraviolet-irradiated male genome in fertilized mouse eggs. Science (1981) 0.90

Active maturation-promoting factor is present in mature mouse oocytes. J Cell Biol (1985) 0.89

Status of genomic imprinting in mouse spermatids. Hum Reprod (1999) 0.89

X-ray sensitivity of the preimplantation mouse embryo in vitro. Radiat Res (1975) 0.89

Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Leukemia (1998) 0.89

Investigation of PNPLA3 and IL28B genotypes on diabetes and obesity after liver transplantation: insight into mechanisms of disease. Am J Transplant (2013) 0.89

Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size. Am J Transplant (2014) 0.89

Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant (2007) 0.88

Timetable of in vivo embryonic development in the grey short-tailed opossum (Monodelphis domestica). Mol Reprod Dev (1994) 0.88

DNA content, ribosomal gene multiplicity, and cell size in fish. J Exp Zool (1971) 0.87

Ultraviolet light-induced unscheduled DNA synthesis in mouse oocytes during meiotic maturation. Nature (1975) 0.87

Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (1999) 0.87

Inhibition of mouse blastocyst attachment and outgrowth by protease inhibitors. J Exp Zool (1981) 0.87

Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant (2009) 0.86

Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant (2012) 0.86

goosecoid expression represses Brachyury in embryonic stem cells and affects craniofacial development in chimeric mice. Int J Dev Biol (2000) 0.86

Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc (2011) 0.85

Development of lethal yellow (Ay-Ay) mouse embryos in vitro. J Exp Zool (1974) 0.85

Mouse embryo attachment to substratum and interaction of trophoblast with cultured cells. J Exp Zool (1979) 0.84

Spectral imaging in preconception/preimplantation genetic diagnosis of aneuploidy: multicolor, multichromosome screening of single cells. J Assist Reprod Genet (1998) 0.84

Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. Obesity (Silver Spring) (2013) 0.84